Dr. Dorothy K. Grange, MD

Dr. Grange practices at St. Louis Children's Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Grange's NPI, 1801812128, was assigned on July 14, 2006. Dr. Grange graduated from University of Florida College of Medicine in 1981. Dr. Grange holds Missouri license R9J19.

Dr. Grange's primary practice is St. Louis Children's Hospital, at One Childrens Place, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 454-6000. Dr. Grange also practices at St Louis Childrens Hospital, 1 Childrens Pl, Saint Louis, MO 63110.

Dr. Grange's primary practice is St. Louis Children's Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Grange to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grange practices. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Grange's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Grange is board certified in clinical genetics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Grange's licenses on file in 4 states: Missouri, Illinois, Maryland and Wisconsin.

CMS counts 13 Medicare patients who saw Dr. Grange in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grange's median patient age at 13, with 48% women.

In 2024, Dr. Grange wrote 39 Medicare Part D claims. 28% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $2,074,341 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Grange for performance year 2024, reported as part of a group. Dr. Grange accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 174 papers to Dr. Grange, published from 2001 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Phenotype, Abnormalities, Multiple and Phenylketonurias. Dr. Grange has published most often in Am J Med Genet A. Dr. Grange's most frequent co-authors are Marwan Suleman Shinawi, MD, Joshua S. Shimony, MD and Robert David Steiner, MD.

Dmand AI links Dr. Grange to 11 clinical trials, 2 of them phase 2 studies. Conditions studied include Ectodermal Dysplasia 1, Anhidrotic, Ectodermal Dysplasia and Phenylketonurias. Edimer Pharmaceuticals sponsors the most, 6.

CMS Open Payments shows 40 general payments to Dr. Grange from 6 drug and device companies from 2016 to 2025. Education make up the largest share, 49% of the total. BioMarin Pharmaceutical Inc. paid the most, $4,785.

Dr. Grange graduated from University of Florida College of Medicine in 1981.

Dr. Grange is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.